Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Cantor Fitzgerald Analyst Reiterates Overweight Rating on 89bio with 29 Price Target

Elaine Mendonca by Elaine Mendonca
March 4, 2024
in Breaking News
0
Finance_Capitalistic
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

On March 4, 2024, analyst Kristen Kluska from Cantor Fitzgerald reiterated an optimistic “Overweight” rating on 89bio (NASDAQ: ETNB) with a price target of $29. This reaffirmation underscores a bullish perspective on the company’s performance and growth potential. Cantor Fitzgerald has continuously supported 89bio with an “Overweight” recommendation, demonstrating unwavering confidence in the stock’s outlook. Despite occasional adjustments to the price target, Cantor Fitzgerald’s consistent endorsement of an “Overweight” rating showcases a favorable view on 89bio’s future direction.

ETNB Stock Price Soars 11.09% on March 4, 2024: Bullish Momentum Signals Strong Performance

On March 4, 2024, ETNB stock showed strong performance as it saw a significant increase in its share price. ETNB is currently trading in the middle of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been performing relatively well compared to its historical performance.

The price of ETNB shares increased by $1.40 since the market last closed, representing a notable 11.09% rise. The stock opened at $16.63, which was $4.01 higher than its previous close. This opening price jump suggests that there was strong demand for ETNB shares at the start of the trading day.

Overall, the positive price momentum and significant increase in share price on March 4th indicate that investors were bullish on ETNB stock. Investors should conduct thorough research and consider their own risk tolerance before making investment decisions.

ETNB Stock Performance: A Closer Look at Financial Data and Profitability Challenges

On March 4, 2024, investors closely monitored the performance of ETNB stock as the company released its financial data. ETNB’s total revenue information was currently unavailable, leaving investors with limited insights into the company’s overall financial health. However, the net income figures provided shed some light on the company’s profitability.

ETNB reported a net income of -$142.19 million over the past year, showing a 39.37% decrease compared to the previous year. In the fourth quarter, the company’s net income was -$40.23 million, which represented a 0.0% change from the previous quarter. These figures indicate that ETNB has been facing challenges in maintaining its profitability over the past year.

In terms of earnings per share (EPS), ETNB reported a figure of -$2.00 for the past year, reflecting a 31.84% increase compared to the previous year. However, in the fourth quarter, the company’s EPS was -$0.50, marking a 9.61% decrease from the previous quarter. This mixed performance in EPS suggests that while there have been some improvements in profitability on a yearly basis, there are still some challenges to overcome in the short term.

Overall, the financial data released by ETNB on March 4, 2024, indicates a mixed performance in terms of profitability. Investors will need to closely monitor the company’s future financial reports to assess whether ETNB can overcome its challenges and drive sustainable growth in the long run.

Tags: ETNB
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Title Astrophysics Breakthrough Discovery of New Celestial Body Challenges Current Understanding of the Universe

Healthcare-and-IT

Amesite Partners with PACE to Revolutionize Healthcare Continuing Education

Market Sentiment Shifts Towards Tetra Tech NYSE TTEK

Recommended

Tilray Stock

Tilray Shares Surge Ahead of Quarterly Earnings Report

4 months ago
Science Applications Stock

Institutional Investors Defy Cautious Analyst Stance on Science Applications

5 months ago
Ballard Power Stock

Institutional Investors Bet Big on Ballard Power Shares

2 months ago
Devon Energy Stock

Devon Energy Shares Show Signs of Revival Amid Strong Fundamentals

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Embecta’s Q1 Performance Outpaces Analyst Forecasts

Camping World’s New Leadership Faces First Major Test

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

Diginex Enters Critical Implementation Phase Following Strategic Moves

Deluxe Stock Gains Momentum on Successful Fintech Transition

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

Trending

Great Lakes Dredge, Dock Stock
Analysis

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

by Rodolfo Hanigan
February 7, 2026
0

As Great Lakes Dredge & Dock prepares to release its upcoming quarterly figures, investor attention is fixed...

Boston Omaha Stock

Investors Await March Report for Boston Omaha’s Strategic Direction

February 7, 2026
Universal Insurance Stock

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

February 7, 2026
Embecta Stock

Embecta’s Q1 Performance Outpaces Analyst Forecasts

February 7, 2026
Camping World Stock

Camping World’s New Leadership Faces First Major Test

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches
  • Investors Await March Report for Boston Omaha’s Strategic Direction
  • Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com